Table 2 Surgical data
From: Pelvic exenteration in gynecologic cancer: complications and oncological outcome
Type of exenteration [n (%)] | |
Total | 15 (65) |
Anterior | 5 (22) |
Posterior | 3 (13) |
Subtype of exenteration [n (%)] | |
Type I (supralevator) | 5 (22) |
Type II (infralevator) | 8 (35) |
Type III (with vulvectomy) | 10 (43) |
Operative time (min) [Mean ± SD (range)] | 439 ± 116 (210–690) |
Subtype of reconstructive surgery [n (%)] | |
Primary closure | 13 (57) |
e-VRAM | 7 (30) |
Neo-vagina | 4 (17) |
Omentoplasty | 10 (43) |
Gracilis flap | 1 (4) |
V-Y flap | 2 (9) |
Ostomy [n (%)] | |
No | 5 (22) |
Colostomy | 18 (78) |
Urinary derivation [n (%)] | |
No | 3 (13) |
Bricker | 19 (83) |
Nephrostomy | 1 (4) |
Lymph node dissection [n (%)] | |
No | 9 (40) |
Inguinal | 4 (17) |
Pelvic | 7 (30) |
Paraortic | 6 (26) |
Other procedures [n (%)] | |
Pubic bone resection | 2 (9) |
Mesh wall repair | 4 (17) |
Intraoperative complications [n (%)] | 1 (4) |
Red blood units transfusion [Mean ± SD (range)] | 0.96 ± 1.15 (0–5) |
Estimated blood loss (ml) [Mean ± SD (range)] | 612 ± 320 (300–1300) |
Margin status [n (%)] | |
R0 | 21 (91) |
R < 1 | 2 (9) |